<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>The Korean Society of Neurogastroenterology and Motility</publisher>
				<availability status="unknown"><p>Copyright The Korean Society of Neurogastroenterology and Motility</p>
				</availability>
				<date type="published" when="2014-04-30">2014-04-30</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Han</forename><forename type="middle">Hee</forename><surname>Lee</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Gastroenterology</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep3">College of Medicine</orgName>
								<orgName type="institution">The Catholic University of Korea</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoon</forename><forename type="middle">Young</forename><surname>Choi</surname></persName>
							<email>choim@catholic.ac.kr</email>
							<affiliation key="aff1">
								<orgName type="department">Department of Surgery, Yonsei University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Myung-Gyu</forename><surname>Choi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Gastroenterology</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep3">College of Medicine</orgName>
								<orgName type="institution">The Catholic University of Korea</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary&apos;s Hospital</orgName>
								<orgName type="institution">The Catholic University of Korea</orgName>
								<address>
									<addrLine>Seocho-Gu</addrLine>
									<postCode>222, 137-701</postCode>
									<settlement>Banpo-daero, Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Neurogastroenterology and Motility</title>
						<title level="j" type="abbrev">J Neurogastroenterol Motil</title>
						<idno type="ISSN">2093-0879</idno>
						<idno type="eISSN">2093-0887</idno>
						<imprint>
							<publisher>The Korean Society of Neurogastroenterology and Motility</publisher>
							<biblScope unit="volume">20</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page" from="152" to="162"/>
							<date type="published" when="2014-04-30" />
						</imprint>
					</monogr>
					<idno type="DOI">10.5056/jnm.2014.20.2.152</idno>
					<idno type="PMID">24840368</idno>
					<idno type="PMCID">PMC4015203</idno>
					<ptr type="open-access" target="http://www.jnmjournal.org/journal/download_pdf.php?doi=10.5056/jnm.2014.20.2.152" />
					<note type="submission">Received: September 5, 2013 Revised: November 27, 2013 Accepted: December 9, 2013</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:14+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Gastrointestinal diseases</term>
					<term>Hypnosis</term>
					<term>Irritable bowel syndrome</term>
					<term>Meta-analysis</term>
					<term>Review</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background/Aims Hypnotherapy is considered as a promising intervention for irritable bowel syndrome (IBS), but the evidence is still limited. The aims of this study were to conduct a systematic review and meta-analysis to estimate the efficacy of hypnotherapy for the treatment of IBS. Methods A literature search was performed using MEDLINE (PubMed), Embase, PsycINFO and the Cochrane Central Register of Controlled Trials (CENTRAL database). Only randomized controlled trials that compared hypnotherapy with any other conventional treatment or no treatment in patients with IBS were included. Studies had to report outcomes as IBS symptom score or quality of life. The mean change in outcome score was used to pool these outcomes for the meta-analysis. Data were synthesized using the standardized mean difference for continuous data. Results Seven randomized controlled trials (6 papers) involving 374 patients with IBS were identified. Performance bias was high in all trials because it was impossible to blind participants and therapists in this type of intervention. The outcomes in this meta-analysis were evaluated at 3 months for short-term effects and at 1 year for long-term effects. The change in abdominal pain score at 3 months was significant in the hypnotherapy group (standardized mean difference,-0.83; 95% CI,-1.65 to-0.01). Three of the 4 trials showed greater improvement in overall gastrointestinal symptoms in the hypnotherapy group. Conclusions This study provides clearer evidence that hypnotherapy has beneficial short-term effects in improving gastrointestinal symptoms of patients with IBS.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain or discomfort associated with altered bowel movements. <ref type="bibr" target="#b0">1</ref> IBS can be diagnosed only when there is no objective evidence of an underlying organic disorder. <ref type="bibr" target="#b1">2</ref> It is one of the most common bowel disorders diagnosed by gastroenterologists. <ref type="bibr" target="#b2">3</ref> The impact of IBS on quality of life (QOL) is as strong as that observed in other serious disorders such as congestive heart failure or chronic renal failure. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> Treatment options include reassurance, dietary modification, and pharmacological treatment. Current pharmacological treatments such as bulking agents, antispasmodics, and antidepressants focus mainly on controlling the symptoms of IBS. However, both pharmacological and conventional options are unsatisfactory in general. <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> Many IBS patients have psychological symptoms such as anxiety and depression, <ref type="bibr" target="#b8">9</ref> which provide a fundamental rationale for psychological treatment. A number of studies have been conducted to evaluate the effects of psychological treatment for IBS. <ref type="bibr" target="#b9">10</ref> Among them, hypnotherapy has gained popularity after the first randomized controlled trial (RCT) in 1984 demonstrating notable benefits of hypnotherapy. <ref type="bibr" target="#b10">11</ref> Several additional studies have also reported benefits of hypnotherapy in treating gastrointestinal symptoms and QOL of IBS patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>12-16</head><p>Previous systematic reviews to prove that there are statistically significant benefits have been based on pooled results of research on the effectiveness of hypnotherapy for IBS patients. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> These reviews concluded that, although a number of studies have shown a beneficial effect of hypnotherapy, insufficient evidence existed to recommend widespread use because of limitations in the sample sizes and methodological flaws. From these conclusions, the National Institute for Health and Clinical Excellence guidelines noted that hypnotherapy is a promising intervention for IBS but the evidence remains to be limited. <ref type="bibr" target="#b18">19</ref> These uncertainties justify a systematic review and meta-analysis to determine whether hypnotherapy has significant beneficial effects in the treatment of IBS. Well-designed RCTs have been conducted, but there is no ongoing RCT; this prompted us to update the previous review. We conducted a comprehensive review of RCTs to estimate the efficacy of hypnotherapy for the treatment of IBS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M aterials and M ethods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Eligibility Criteria</head><p>The inclusion criteria in this study were specified in advance and followed the population, intervention, comparison and outcome(s) (PICO) study design: patients who had been diagnosed with IBS as the population of interest, given hypnotherapy as an intervention, or given any other conventional treatment or no treatment for comparison. Outcomes were overall gastrointestinal symptoms, individual gastrointestinal symptoms (abdominal pain, constipation and diarrhea) and QOL, which were measured as scores. Any studies that reported at least one of these outcomes were included. Only RCTs were included in this meta-analysis to provide more unbiased information than that obtained from other study designs. There was no limitation on publication language, study size or study setting. Patients were not otherwise restricted by age or ethics. Studies that included a comparison between different types of hypnotherapy were excluded.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Search Strategy</head><p>A literature search was conducted using MEDLINE (PubMed), Embase, PsycINFO, and the Cochrane Central Register of Controlled Trials (CENTRAL database) from January 15, 2013. The search was performed using the Medical Subject Headings (MeSH): "colonic diseases," "colonic diseases, functional," "irritable bowel syndrome," and "hypnosis." Other free-text search terms used were "irritable bowel syndrome," "hypnotherapy," "hypnosis," "mesmerism," "imagery" and "autohypnosis." Search terms were adapted according to each particular database. The strategy was refined further by a local health care librarian to ensure a good balance of sensitivity and specificity. Electronic searches were supplemented by manually searching the bibliographies of eligible clinical trials and previous systematic reviews.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Selection and Data Extraction</head><p>Two authors (H.H.L. and Y.Y.C.) independently screened the titles and abstracts of the papers identified by the initial search for relevance to this review. We retrieved the full text for any citation deemed potentially eligible at this stage. Two authors then separately assessed full articles using predetermined inclusion criteria to exclude irrelevant articles. Any disagreements regarding study inclusion were resolved by discussion. Data from the in- cluded studies were extracted by 2 authors to a Microsoft Excel spreadsheet (XP Professional; Microsoft Corp, Redmond, WA, USA). Conflicts in data extraction were resolved by consensus after referring back to the original article.</p><p>Searches of 4 of the electronic bibliographic databases initially identified 139 potentially relevant citations. Two additional studies were found by cross-referencing. Our search strategy identified 98 citations after removing duplicates, 30 of which were retrieved for full-text assessment, and a total of 7 RCTs ultimately fulfilled our inclusion criteria <ref type="figure" target="#fig_0">(Fig. 1)</ref>. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> One study reported 2 RCTs being conducted on different settings in one publication. <ref type="bibr" target="#b19">20</ref> One of the studies that we initially excluded was published only in abstract form. As we were conducting our meta-analysis, advance online publication of this study was reported in February 2013, so we have included it in our review.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>24</head><p>Agreement between authors for trial eligibility was substantial (k statistic = 0.79).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quality Assessment</head><p>Two authors independently assessed the methodological quality of the included trials using the risk of bias tool recommended by the Cochrane Collaboration. <ref type="bibr" target="#b24">25</ref> This included random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, assessment of incomplete data outcome, selective reporting and other sources of bias. For each trial, the risk of bias was reported as "low risk," "unclear risk" or "high risk." Disagreement was resolved by discussion.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Analysis</head><p>All the assessed outcomes were continuous variables. Although the studies included in our review reported similar outcomes, various measurement instruments were applied to calculate the scores. The mean change in the outcome score was calculated and used to compare these outcomes by subtracting the baseline score from the score after treatment. The standard devia-  tion (SD) is needed for use of the change score in a meta-analysis. One trial presented the standard deviation of the changes in their report. <ref type="bibr" target="#b19">20</ref> From these data, we calculated the correlation coefficient by using the following formula. We also used the following formula to calculate the SD of the change by using the correlation coefficient in the studies that did not report this value. To combine the different scales, we used the standardized mean difference (SMD) rather than the actual means because the SMD does not depend on the measurement scale. To evaluate the magnitude of the effect size calculated by SMD, Cohen's categories were used with 0.0-0.2 = not a substantial effect size, ＞ 0.2-0.5 = a small effect size, ＞ 0.5-0.8 = a medium effect size, and ＞ 0.8 = a large effect size.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>26</head><p>Meta-analysis was performed using the software Review Manager version 5.2.3 (RevMan for Windows 7; the Nordic Cochrane Center, Copenhagen, Denmark) provided by the Cochrane Collaboration. Meta-analysis was performed using a fixed-effects model and a random-effects model for each outcome, and the analyses were compared. A P-value ＜ 0.05 was considered significant.</p><p>Statistical heterogeneity among studies was assessed using the χ 2 test, defining a significant heterogeneity as a P-value ＜ 0.1, and was quantified by measuring I</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2</head><p>. An I 2 value ＞ 50% suggested significant statistical heterogeneity. The fixed-effects model of meta-analysis was used in the case of statistical homogeneity, whereas in the case of statistical heterogeneity, the random-effects model was applied. Analysis and reporting followed the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) guidelines. <ref type="bibr" target="#b26">27</ref> Forest plots of SMDs for the assessed outcomes with 95% confidence intervals (CIs) and funnel plots were generated. The latter were assessed for evidence of asymmetry and therefore possible reporting bias or publication bias. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Description of Included Studies</head><p>The characteristics of the included studies are shown in <ref type="table" target="#tab_0">Table 1</ref>. A total of 374 patients (74 men and 300 women) were included in this meta-analysis: 191 patients were in the hypnotherapy group and 183 patients were in the control group. Gut-directed hypnotherapy (GDH) was applied to the patients as an intervention in all 7 trials. The frequency of this intervention varied from 5 to 12 sessions, and the duration of each session varied from 30 to 60 minutes. Three of the included trials used the Manchester protocol for GDH. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b27">28</ref> Moser et al delivered GDH in group sessions. <ref type="bibr" target="#b23">24</ref> Four trials performed GDH with usual medical therapy or supportive talks and medical treatment. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Various methods were used for the control groups. Four trials monitored symptoms only in the control group, <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> and others provided supportive and medical therapy.</p><p>All trials included as outcomes IBS-related gastrointestinal symptoms. QOL was assessed in 4 trials. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> No adverse events were reported in any trial.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk of Bias</head><p>The quality of RCTs included in our review was assessed by the Cochrane risk of bias tool <ref type="figure" target="#fig_1">(Fig. 2)</ref>. Selection bias was shown in one trial because its method was not optimal for ensuring adequate allocation concealment. <ref type="bibr" target="#b20">21</ref> Performance bias was high in all trials because it was not possible to blind participants and therapists in this type of intervention. Attrition bias was high in 2 trials. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Other type of bias was high in one trial. Four trials used intention-to-treat analysis, <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b23">24</ref> and the others did not.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects</head><p>The data for 6 of the 7 included RCTs were pooled for analysis. <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> The data of one study were not available for analysis after we tried unsuccessfully to correspond with the author.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>11</head><p>The outcomes were evaluated at 3 months for short-term effects. In the cases of short-term effects, although some studies reported their results at 2 or 4 months, we regarded them as the same period as 3 months. The long-term outcomes were measured at 1 year.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abdominal pain</head><p>Four RCTs reported an abdominal pain change score.  Three reported it at 3 months, <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref> which showed a significant difference in favor of the GDH group (SMD -0.83; 95% CI, -1.65 to -0.01; P = 0.050) <ref type="figure" target="#fig_2">(Fig. 3A)</ref>. The random-effects model was used because there was considerable heterogeneity (I 2 = 77%, P = 0.010). Based on Cohen's categories, the effect size of the abdominal pain change score at 3 months was large. The ab-dominal pain change score at 1 year was reported by 2 of the 4 RCTs. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Meta-analysis using the fixed-effects model showed a significant difference in favor of the GDH group (SMD, -0.53; 95% CI, -0.90 to -0.15; P = 0.006). However, there was considerable heterogeneity (I 2 = 84%, P = 0.010). When the randomeffects model was used, there was no significant difference (SMD, -0.52; 95% CI, -1.47 to 0.44; P = 0.290) <ref type="figure" target="#fig_2">(Fig. 3B</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Constipation and diarrhea</head><p>The constipation change score was reported by 3 RCTs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>20,23,24</head><p>Two of these 3 trials reported this score at 3 months, <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23</ref> and this value did not change significantly (SMD, -0.12; 95% CI, -0.49 to 0.25; P = 0.520) <ref type="figure" target="#fig_4">(Fig. 4A)</ref>. The constipation change score at 1 year was reported by 2 of the 3 RCTs. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Meta-analysis showed no significant difference (SMD, -0.33; 95% CI, -0.70 to 0.04; P = 0.080) <ref type="figure" target="#fig_4">(Fig. 4B)</ref>. Meta-analysis of the diarrhea change score at 3 months was reported by 2 RCTs, <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23</ref> and there was no significant difference (SMD, -0.36; 95% CI, -0.74 to 0.01; P = 0.060) <ref type="figure" target="#fig_4">(Fig. 4C)</ref>. The diarrhea change score at 1 year was reported by 2 RCTs, <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> and the meta-analysis showed no significant difference (SMD, -0.16; 95% CI, -0.52 to 0.21; P = 0.400) ( <ref type="figure" target="#fig_4">Fig. 4D</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Overall gastrointestinal symptoms</head><p>Four trials attempted to measure the overall gastrointestinal symptom score in IBS patients <ref type="table" target="#tab_3">(Table 2)</ref>. Different studies used different assessment tools, and these studies were not eligible to be combined for the meta-analysis. Three trials showed that the hypnotherapy group had greater improvement in the overall gastrointestinal symptom score at 3 months compared with the control group, whereas the difference in the symptom score did not differ significantly between the 2 groups in the other trial. Only one trial reported the result at 1 year, and there was no significant difference between the hypnotherapy group and control group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>23</head><p>The studies by Lindfors et al <ref type="bibr" target="#b19">20</ref> (studies 1 and 2 in <ref type="table" target="#tab_3">Table 2</ref>) did not report the overall gastrointestinal symptom scores at 12 months in the control group because it was considered unethical to not allow the controls to receive hypnotherapy available in their clinical settings. Thus, we could not compare the change in overall gastrointestinal symptom scores at 12 months between the hypnotherapy and control groups.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quality of life</head><p>Four RCTs measured QOL. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Two used a generic health-related QOL measure (short-form 36 health survey ). <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b23">24</ref> Study 2 of Lindfors et al 20 showed no significant differences in SF-36 scores between the GDH group and control group. Moser et al <ref type="bibr" target="#b23">24</ref> reported a significant improvement in QOL scores at 3 months and 1 year in 4 dimensions (role physical, general health, vitality and social functioning) and at 1 year in 3 more dimensions (physical functioning, bodily pain and mental health) compared with the control groups. Three trials used disease-specific QOL instruments.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>20,23,24</head><p>Roberts et al used an IBS-specific QOL measure <ref type="bibr" target="#b12">13</ref> and found no significant difference in QOL scores between the hypnotherapy and control groups at 3 months and 1 year. <ref type="bibr" target="#b22">23</ref> Study 1 of Lindfors et al <ref type="bibr" target="#b19">20</ref> used an IBS-specific QOL measure <ref type="bibr" target="#b28">29</ref> and reported a significant improvement at 3 months in the GDH group in the dimensions of mental health, sleep, energy and social role versus baseline. <ref type="bibr" target="#b19">20</ref> This improvement was maintained significantly at 1 year, and additional improvement in emotional functioning was identified. However, there was no significant difference in the changes in QOL at 3 months between the GDH group and control group. Moser et al <ref type="bibr" target="#b23">24</ref> used an IBS-impact scale, a disease-specific documentation of the impact of IBS on patients' lives. <ref type="bibr" target="#b29">30</ref> In this study, the hypnotherapy group showed a significant improvement in IBS-impact scale scores at 3 months and 1 year compared with the control group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>We reviewed 7 RCTs with a total of 374 patients that compared hypnotherapy with various control treatments to examine whether hypnotherapy as treatment for IBS would have sig-nificant beneficial effects on gastrointestinal symptoms and QOL. This review is the first study to conduct a meta-analysis of the efficacy of hypnotherapy in IBS patients. This meta-analysis revealed that hypnotherapy significantly improved abdominal pain, at least at short-term follow-up. Hypnotherapy also provided benefit for overall gastrointestinal symptoms. However, evidence for the long-term efficacy of hypnotherapy is lacking because of an insufficient number of studies.</p><p>Our search strategy was comprehensive in that we used 4 databases, distinct inclusion criteria and the Cochrane risk of bias tool for each trial. The previous reviews included insufficient evidences because of the small number of RCTs and methodological flaws. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> Our study provides more reliable evidence by including 3 recent well-designed RCTs.</p><p>Randomization is especially important in trials of fluctuating diseases such as IBS, since recruitment of patients to a trial usually occurs during a period of increased symptomatology. <ref type="bibr" target="#b16">17</ref> The current study included only RCTs whose aim was to establish the effectiveness of hypnotherapy. The calculation of a summary measure of effect had been difficult because of heterogeneity in the outcome measures in the previous reviews. Likert scales of different grades were used to obtain scores for abdominal pain and symptoms of defecatory dysfunction in individual trials. In this meta-analysis, we used the SMD as a summary statistic for studies that assessed the same outcome but measured it with different methods. In this meta-analysis, the potential benefits of hypnotherapy in treating constipation and diarrhea were not verified because of insufficient power and internal validity. In addition, patient-reported ratings of changes in bowel habits were not able to delineate adequately whether any benefits were achieved in all of the important subconcepts (i.e., urgency, stool consistency and stool frequency). Further trials should include a predefined definition and grade for bowel habits such as the British stool scale to evaluate benefits precisely.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>31</head><p>GDH involves hypnotic induction by using a variety of techniques, including progressive relaxation, followed by creating imagery related to symptom control and normalization of gut function. The mechanism through which hypnotherapy improves abdominal pain in IBS patients is not well understood. Hypnotic reduction of somatic pain is thought to reduce the activation of certain areas of the brain, which appears to be exaggerated in IBS. <ref type="bibr" target="#b31">32</ref> It is also assumed that hypnotherapy normalizes visceral sensation, decreases colonic phasic contractions, and reverses negative thoughts of IBS patients about their condition.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>33-35</head><p>Although 3 more RCTs were added in this meta-analysis after the last systematic review, the number of included studies was too small to draw firm conclusions. The control groups varied somewhat between studies, from no treatment to supportive therapy; however, separate comparisons of the different control treatments were not conducted because of the limited number of included trials. Difficulties in blinding because of the nature of the intervention also contribute to the potential for performance bias.</p><p>In conclusion, hypnotherapy may be a useful and safe therapeutic option for refractory IBS in short term. More high-quality RCTs are needed for evaluating the long-term efficacy of hypnotherapy. All of the included studies targeted refractory IBS; therefore, the beneficial effects of hypnotherapy cannot be generalized to all IBS patients.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Flow diagram of studies identified in the systematic review. IBS, irritable bowel syndrome; RCT, randomized controlled trial.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Assessment of risk of bias in this meta-analysis. Risk of bias summary. (A) Summary of risk of bias for each trial assessed by Cochrane Collaboration' tool, plus sign was for a judgment of Yes or low risk of bias, minus sign was for a judgment of No or high risk of bias, and question mark was for a judgment of Unclear, or uncertain risk of bias, which meant there was insufficient information to permit a judgment of Yes or No. Risk of bias graph. (B) Risk of bias graph about each risk of bias item presented as percentages across all included studies.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Forest plots of abdominal pain change score. (A) Meta-analysis of 3 months results. (B) Meta-analysis of 1-year results. GDH, gut-directed hypnotherapy; Std., standardized.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>20, 22 - 24</head><label>2224</label><figDesc></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc>Forest plots of constipation change score at 3 months (A) and 1 year (B), diarrhea change score at 3 months (C) and 1 year (D). GDH, gut-directed hypnotherapy; Std., standardized.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc></figDesc><table><row><cell></cell><cell>Scale</cell><cell>4-graded Likert scale (none [0] to severe [3]) 4-graded Likert scale (no improvement [0] to maximum improvement [3])</cell><cell>5-graded Likert scale (symptom absent [0] to debilitating symptom [4])</cell><cell cols="2">5-graded Likert scale (none [0] to incapacitating [4]) 4-graded Likert scale (hard, firm, soft and watery)</cell><cell>0-100 scale (increasing scores denoting more severe symptoms)</cell><cell>7-graded Likert scale (none [1] to very severe [7]): total symptom severity score (7-49)</cell><cell>0-100 scale (100 representing the best possible QOL)</cell><cell>4-graded Likert scale (0-3)</cell></row><row><cell></cell><cell>Outcomes</cell><cell>Abdominal pain Abdominal distension Bowel habit General wellbeing</cell><cell>CPSR</cell><cell>Abdominal pain Bloating</cell><cell>Proportion of hard or loose stools Bowel movements per day</cell><cell>IBS-specific QOL (8 dimensions: dysphoria, inter-ference with activity, body image, health worry, food avoi-dance, social reac-tion, sexual function and relationships) Full symptom score (3 dimensions: pain, constipation and diarrhea)</cell><cell cols="2">GI-symptom questionnaire (2 domains: sensory symptoms score [pain, bloating and gas] and bowel habit score [loose stools, urgency, hard stools and incomplete evacuation]) IBS-QOL (9 dimensions: emotional function-ing, mental health, sleep, energy, physi-cal functioning, diet, social role, physical role and sexual relations) The HAD scale (14 items, with 7 items relating to anxiety and 7 items related to depression)</cell></row><row><cell></cell><cell>Allowed other medication</cell><cell>NA</cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>Usual medical therapy</cell><cell>Antidiarrheals, bulking agents, spasmolytics</cell></row><row><cell></cell><cell>Control</cell><cell>Placebo with supportive psychotherapy : 7 sessions of 30 min</cell><cell>Symptom monitoring</cell><cell>Symptom monitoring</cell><cell></cell><cell>Symptom monitoring</cell><cell>Dietary advice Information about relaxation training Education Nursing support by telephone</cell></row><row><cell></cell><cell>Intervention</cell><cell>GDH: 7 sessions of 30 min+ autohypnosis</cell><cell>GDH: 12 sessions of 30-60 min</cell><cell cols="2">GDH: 7 sessions of 45 min</cell><cell>GDH: 5 sessions of 30 min</cell><cell>GDH (Manchester protocol): 12 sessions of 60 min+ autohypnosis</cell></row><row><cell></cell><cell>No. of patients (intervention: control)</cell><cell>15:15</cell><cell>5:6</cell><cell>15:9</cell><cell></cell><cell>40:41</cell><cell>45:45</cell></row><row><cell></cell><cell>Age (range, yr) Sex (M:F)</cell><cell>24-53 4:26</cell><cell>23-58 2:9</cell><cell>Mean 39.1 9:15</cell><cell></cell><cell>18-65 12:69</cell><cell>21-68 19:71</cell></row><row><cell></cell><cell>Exclusion criteria</cell><cell>Organic GI disease, psychiatric disorder</cell><cell>Psychiatric disorder, language barrier</cell><cell cols="2">Abdominal surgery history, organic GI disease, psychotropic medication</cell><cell>Atypical GI symptoms Aged over 65 years</cell><cell>Organic GI disease, severe co-existing disease, psychotropic drugs or antidepressants</cell></row><row><cell>Characteristics of Included Studies</cell><cell>Country (setting) Population Definition of IBS</cell><cell>UK (university hospital) Refractory IBS, at least 1 year Abdominal pain, a disordered bowel habit, and abdominal distention (predated the Rome criteria)</cell><cell>USA Refractory IBS, at least 6 months Rome I, diagnosed by physician or gastroentero-logist</cell><cell cols="2">USA Refractory IBS, at least 1 year Rome I</cell><cell>UK Refractory IBS, at least 6 months Diagnosed by general practitioner (criteria used IBS diagnosis not specified)</cell><cell>Sweden (university hospital) Refractory IBS Rome II</cell></row><row><cell></cell><cell>Author (yr)</cell><cell>Whorwell et al 11 (1984)</cell><cell>Galovski et al 21 (1998)</cell><cell cols="2">Palsson et al 22 (2002)</cell><cell>Roberts et al 23 (2006)</cell><cell>Lindfors et al 20 (2012) study 1</cell></row></table><note>IBS, irritable bowel syndrome; GI, gastrointestinal; FAP, functional abdominal pain; GDH, gut-directed hypnotherapy; NA, not allowed; CPSR, composite primary symptom reduction; QOL, quality of life; GSRS, gastrointestinal symptom rating scale; SF-36, short form 36; HAD, hospital anxiety and depression; SMT, supportive talks and medical treatment.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc>Change in Overall Gastrointestinal Symptom Score</figDesc><table><row><cell>Author (yr)</cell><cell>Outcome measurement</cell><cell cols="2">3 months Intervention (SD) Control (SD)</cell><cell>P-value</cell><cell cols="2">12 months Intervention (SD) Control (SD)</cell><cell>P-value</cell></row><row><cell>Galovski et al 21 (1998)</cell><cell>CPSR a</cell><cell>-0.55 (0.53)</cell><cell>0.32 (0.49)</cell><cell>0.00047</cell><cell>NA</cell><cell>NA</cell><cell>NA</cell></row><row><cell>Roberts et al 23 (2006)</cell><cell>Full symptom score</cell><cell>-13.00 (10.50)</cell><cell>-4.5 (13.90)</cell><cell>0.008</cell><cell cols="3">-9.10 (14.00) -6.40 (14.70) 0.440</cell></row><row><cell cols="2">Lindfors et al 20 (2012) study 1 GI-symptom questionnaire</cell><cell>-4.50 (8.60)</cell><cell cols="2">-0.80 (7.30) ＜ 0.05</cell><cell>NA</cell><cell>NA</cell><cell>NA</cell></row><row><cell cols="2">Lindfors et al 20 (2012) study 2 GSRS-IBS</cell><cell>-0.43 (0.90)</cell><cell>-0.10 (1.00)</cell><cell>0.220</cell><cell>NA</cell><cell>NA</cell><cell>NA</cell></row><row><cell cols="2">a CPSR was measured at right after end of treatment.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="8">SD, standard deviation; CPSR, composite primary symptom reduction; NA, not allowed; GSRS, gastrointestinal symptom rating scale; IBS, irritable bowel syndrome.</cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Functional bowel disorders and functional abdominal pain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Longstreth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Drossman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">W</forename><surname>Heaton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Irvine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Muller-Lissner</surname></persName>
		</author>
		<idno type="DOI">10.1136/gut.45.2008.ii43</idno>
		<idno type="PMID">10457044</idno>
		<idno type="ark">ark:/67375/NVC-X6SBM5VJ-1</idno>
		<idno type="istexId">1B71A71D13191BAA40A15D0B1BEB119B93D5808F</idno>
		<ptr type="open-access" target="https://gut.bmj.com/content/45/suppl_2/II43.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<title level="j" type="abbrev">Gut</title>
		<idno type="ISSN">0017-5749</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">Supplement 2</biblScope>
			<biblScope unit="page" from="ii43" to="ii47" />
			<date type="published" when="1999-09-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gülcan</forename><forename type="middle">S</forename><surname>Karabulut</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ömer</forename><forename type="middle">F</forename><surname>Beşer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ethem</forename><surname>Erginöz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tufan</forename><surname>Kutlu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fügen</forename><forename type="middle">Ç</forename><surname>Çokuğraş</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tülay</forename><surname>Erkan</surname></persName>
		</author>
		<idno type="DOI">10.5056/jnm.2013.19.1.90</idno>
		<idno type="PMID">23350053</idno>
		<idno type="PMCID">PMC3548133</idno>
		<ptr type="open-access" target="http://www.jnmjournal.org/journal/download_pdf.php?doi=10.5056/jnm.2013.19.1.90" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neurogastroenterology and Motility</title>
		<title level="j" type="abbrev">J Neurogastroenterol Motil</title>
		<idno type="ISSN">2093-0879</idno>
		<idno type="ISSNe">2093-0887</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="90" to="93" />
			<date type="published" when="2013-01-31" />
			<publisher>The Korean Society of Neurogastroenterology and Motility</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Irritable bowel syndrome: diagnosis and management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.332.7536.280</idno>
		<idno type="PMID">16455728</idno>
		<idno type="PMCID">PMC1360402</idno>
		<idno type="ark">ark:/67375/NVC-RRRHN1ZM-H</idno>
		<idno type="istexId">B4B274687A70EAF2A88404B561E11D11B2790B65</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1360402?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<title level="j" type="abbrev">BMJ</title>
		<idno type="ISSN">0959-8138</idno>
		<idno type="ISSNe">1468-5833</idno>
		<imprint>
			<biblScope unit="volume">332</biblScope>
			<biblScope unit="issue">7536</biblScope>
			<biblScope unit="page" from="280" to="283" />
			<date type="published" when="2006-02-02" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Impact of irritable bowel syndrome on quality of life</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">E</forename><surname>Whitehead</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">K</forename><surname>Burnett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edwin</forename><forename type="middle">W</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><surname>Taub</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf02071408</idno>
		<idno type="PMID">8943980</idno>
		<idno type="ark">ark:/67375/1BB-05N99MW9-L</idno>
		<idno type="istexId">6E83DA028876B0CA70CB7806D2C79A3185562AE6</idno>
	</analytic>
	<monogr>
		<title level="j">Digestive Diseases and Sciences</title>
		<title level="j" type="abbrev">Digest Dis Sci</title>
		<idno type="ISSN">0163-2116</idno>
		<idno type="ISSNe">1573-2568</idno>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2248" to="2253" />
			<date type="published" when="1996-11" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The impact of irritable bowel syndrome on health-related quality of life</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><forename type="middle">M</forename><surname>Gralnek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ron</forename><forename type="middle">D</forename><surname>Hays</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amy</forename><surname>Kilbourne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruce</forename><surname>Naliboff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emeran</forename><forename type="middle">A</forename><surname>Mayer</surname></persName>
		</author>
		<idno type="DOI">10.1053/gast.2000.16484</idno>
		<idno type="PMID">10982758</idno>
		<idno type="PII">S0016-5085(00)47757-7</idno>
		<idno type="ark">ark:/67375/6H6-XQRCK0T0-G</idno>
		<idno type="istexId">765E40FD1AD558178461A7B981484491BF60FAC0</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<title level="j" type="abbrev">Gastroenterology</title>
		<idno type="ISSN">0016-5085</idno>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="654" to="660" />
			<date type="published" when="2000-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Otto</forename><surname>Quartero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Villy</forename><surname>Meiniche-Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><surname>Muris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Niek</forename><surname>De Wit</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd003460.pub2</idno>
		<idno type="PMID">15846668</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">3460</biblScope>
			<date type="published" when="2005-04-20" />
			<publisher>John Wiley &amp; Sons, Ltd</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Bran and irritable bowel syndrome: time for reappraisal</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Y</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(94)91055-3</idno>
		<idno type="PMID">7912305</idno>
		<idno type="PII">S0140-6736(94)91055-3</idno>
		<idno type="ark">ark:/67375/6H6-9BHXR60Q-8</idno>
		<idno type="istexId">7A4C01C5D9DF2ACAA0375EC18D39CD85DA2F1846</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">344</biblScope>
			<biblScope unit="issue">8914</biblScope>
			<biblScope unit="page" from="39" to="40" />
			<date type="published" when="1994-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Poynard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Regimbeau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Benhamou</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2036.2001.00937.x</idno>
		<idno type="PMID">11207510</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/4e29/4c36c7d5e0edde72ba4e3d85a957c1c3acf9.pdf" />
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology and Therapeutics</title>
		<title level="j" type="abbrev">Aliment Pharmacol Ther</title>
		<idno type="ISSN">0269-2813</idno>
		<idno type="ISSNe">1365-2036</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="355" to="361" />
			<date type="published" when="2001-03-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">AGA technical review on irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">A</forename><surname>Drossman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Camilleri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emeran</forename><forename type="middle">A</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">E</forename><surname>Whitehead</surname></persName>
		</author>
		<idno type="DOI">10.1053/gast.2002.37095</idno>
		<idno type="PMID">12454866</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<title level="j" type="abbrev">Gastroenterology</title>
		<idno type="ISSN">0016-5085</idno>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2108" to="2131" />
			<date type="published" when="2002-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Psychological Treatments for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">M</forename><surname>Lackner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christina</forename><surname>Mesmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><surname>Morley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clare</forename><surname>Dowzer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simon</forename><surname>Hamilton</surname></persName>
		</author>
		<idno type="DOI">10.1037/0022-006x.72.6.1100</idno>
		<idno type="PMID">15612856</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Consulting and Clinical Psychology</title>
		<title level="j" type="abbrev">Journal of Consulting and Clinical Psychology</title>
		<idno type="ISSN">0022-006X</idno>
		<idno type="ISSNe">1939-2117</idno>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1100" to="1113" />
			<date type="published" when="2004" />
			<publisher>American Psychological Association (APA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">CONTROLLED TRIAL OF HYPNOTHERAPY IN THE TREATMENT OF SEVERE REFRACTORY IRRITABLE-BOWEL SYNDROME</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alison</forename><surname>Prior</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">B</forename><surname>Faragher</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(84)92793-4</idno>
		<idno type="PMID">6150275</idno>
		<idno type="PII">S0140-6736(84)92793-4</idno>
		<idno type="ark">ark:/67375/6H6-0CVZLBG7-1</idno>
		<idno type="istexId">2BB6CB920DDE6C3E6728F3F5EABBDD67F59A51B4</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="issue">8414</biblScope>
			<biblScope unit="page" from="1232" to="1234" />
			<date type="published" when="1984-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Hypnotherapy in severe irritable bowel syndrome: further experience.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Prior</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Colgan</surname></persName>
		</author>
		<idno type="DOI">10.1136/gut.28.4.423</idno>
		<idno type="PMID">3583070</idno>
		<idno type="PMCID">PMC1432815</idno>
		<idno type="ark">ark:/67375/NVC-F6TSJXS4-J</idno>
		<idno type="istexId">42140D38171CA48361C4613A1EAD5EAD05EE2B6A</idno>
		<ptr type="open-access" target="https://gut.bmj.com/content/28/4/423.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<title level="j" type="abbrev">Gut</title>
		<idno type="ISSN">0017-5749</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="423" to="425" />
			<date type="published" when="1987-04-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">INDIVIDUAL AND GROUP HYPNOTHERAPY IN TREATMENT OF REFRACTORY IRRITABLE BOWEL SYNDROME</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">F</forename><surname>Harvey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Gunary</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Hinton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Barry</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(89)90013-5</idno>
		<idno type="PMID">2563797</idno>
		<idno type="PII">S0140-6736(89)90013-5</idno>
		<idno type="ark">ark:/67375/6H6-JHJZ4HM0-J</idno>
		<idno type="istexId">1145659A010E511565E780470BB9F9A82F0AD810</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="issue">8635</biblScope>
			<biblScope unit="page" from="424" to="425" />
			<date type="published" when="1989-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Syuptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Houghton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Heyman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2036.1996.tb00181.x</idno>
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology &amp; Therapeutics</title>
		<idno type="ISSN">0269-2813</idno>
		<idno type="ISSNe">1365-2036</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="91" to="95" />
			<date type="published" when="2007-03-31" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><forename type="middle">M</forename><surname>Gonsalkorale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lesley</forename><forename type="middle">A</forename><surname>Houghton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1572-0241.2002.05615.x</idno>
		<idno type="PMID">12003432</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Gastroenterology</title>
		<title level="j" type="abbrev">Am J Gastroenterology</title>
		<idno type="ISSN">0002-9270</idno>
		<idno type="ISSNe">1572-0241</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="954" to="961" />
			<date type="published" when="2002-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Long term benefits of hypnotherapy for irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">M</forename><surname>Gonsalkorale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Afzal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1136/gut.52.11.1623</idno>
		<idno type="PMID">14570733</idno>
		<idno type="PMCID">PMC1773844</idno>
		<idno type="ark">ark:/67375/NVC-1FXCL4B0-P</idno>
		<idno type="istexId">6427D87145CB9EDA1E5DFEF5B0178C01B3A7940F</idno>
		<ptr type="open-access" target="https://gut.bmj.com/content/52/11/1623.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<title level="j" type="abbrev">Gut</title>
		<idno type="ISSN">0017-5749</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1623" to="1629" />
			<date type="published" when="2003-11-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Greenfield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S; Birmingham Ibs Research</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2036.2006.03028.x</idno>
		<idno type="PMID">16918880</idno>
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology and Therapeutics</title>
		<title level="j" type="abbrev">Aliment Pharmacol Ther</title>
		<idno type="ISSN">0269-2813</idno>
		<idno type="ISSNe">1365-2036</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="769" to="780" />
			<date type="published" when="2006-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Hypnotherapy for treatment of irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annette</forename><forename type="middle">N</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renata</forename><surname>Kukuruzovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">G</forename><surname>Catto-Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">M</forename><surname>Sawyer</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd005110.pub2</idno>
		<idno type="PMID">17943840</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database of Systematic Reviews</title>
		<idno type="ISSNe">1465-1858</idno>
		<imprint>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">5110</biblScope>
			<date type="published" when="2007-10-17" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care</title>
	</analytic>
	<monogr>
		<title level="j">London: Royal College of Nursing</title>
		<imprint>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
	<note>National Collaborating Center for Nursing and Supportive Care (UK)</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Effects of Gut-Directed Hypnotherapy on IBS in Different Clinical Settings—Results From Two Randomized, Controlled Trials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Perjohan</forename><surname>Lindfors</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Unge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrik</forename><surname>Arvidsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henry</forename><surname>Nyhlin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Einar</forename><surname>Björnsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hasse</forename><surname>Abrahamsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magnus</forename><surname>Simrén</surname></persName>
		</author>
		<idno type="DOI">10.1038/ajg.2011.340</idno>
		<idno type="PMID">21971535</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Gastroenterology</title>
		<title level="j" type="abbrev">Am J Gastroenterol</title>
		<idno type="ISSN">0002-9270</idno>
		<idno type="ISSNe">1572-0241</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="276" to="285" />
			<date type="published" when="2011-10-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The treatment of irritable bowel syndrome with hypnotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">E</forename><surname>Galovski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">B</forename><surname>Blanchard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Appl Psychophysiol Biofeedback</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="219" to="232" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">S</forename><surname>Palsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">K</forename><surname>Burnett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">E</forename><surname>Whitehead</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dig Dis Sci</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="2605" to="2614" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary carebased randomised controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Roalfe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Greenfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Gen Pract</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="115" to="121" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Long-Term Success of GUT-Directed Group Hypnosis for Patients With Refractory Irritable Bowel Syndrome: A Randomized Controlled Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriele</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silja</forename><surname>Trägner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ewelina</forename><forename type="middle">Elwira</forename><surname>Gajowniczek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Mikulits</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Michalski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lili</forename><surname>Kazemi-Shirazi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefanie</forename><surname>Kulnigg-Dabsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martina</forename><surname>Führer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elisabeth</forename><surname>Ponocny-Seliger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clemens</forename><surname>Dejaco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wolfgang</forename><surname>Miehsler</surname></persName>
		</author>
		<idno type="DOI">10.1038/ajg.2013.19</idno>
		<idno type="PMID">23419384</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Gastroenterology</title>
		<title level="j" type="abbrev">Am J Gastroenterol</title>
		<idno type="ISSN">0002-9270</idno>
		<idno type="ISSNe">1572-0241</idno>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="602" to="609" />
			<date type="published" when="2013-02-19" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Cochrane handbook for systematic reviews of interventions: version 5.1.0</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<ptr target="http://www.cochrane-handbook.org" />
		<imprint>
			<date type="published" when="2011-01-26" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Statistical Power Analysis for the Behavioral Sciences</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jacob</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.4324/9780203771587</idno>
		<imprint>
			<date type="published" when="2013-05-13" />
			<publisher>Routledge</publisher>
			<pubPlace>Hillsdale (NJ</pubPlace>
		</imprint>
	</monogr>
	<note>2nd ed.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alessandro</forename><surname>Liberati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Tetzlaff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2009.06.005</idno>
		<idno type="PMID">19631508</idno>
		<ptr type="open-access" target="https://air.unimi.it/bitstream/2434/211629/2/prisma_clin%20epidemiol.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Epidemiology</title>
		<title level="j" type="abbrev">Journal of Clinical Epidemiology</title>
		<idno type="ISSN">0895-4356</idno>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1006" to="1012" />
			<date type="published" when="2009-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Hypnotherapy for Children With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Controlled Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arine</forename><forename type="middle">M</forename><surname>Vlieger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carla</forename><surname>Menko–frankenhuis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simone</forename><forename type="middle">C S</forename><surname>Wolfkamp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ellen</forename><surname>Tromp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><forename type="middle">A</forename><surname>Benninga</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2007.08.072</idno>
		<idno type="PMID">17919634</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<title level="j" type="abbrev">Gastroenterology</title>
		<idno type="ISSN">0016-5085</idno>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1430" to="1436" />
			<date type="published" when="2007-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Kirchdoerfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fullerton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Mayer</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2036.1997.00168.x</idno>
		<idno type="PMID">9218081</idno>
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology and Therapeutics</title>
		<title level="j" type="abbrev">Aliment Pharmacol Ther</title>
		<idno type="ISSN">0269-2813</idno>
		<idno type="ISSNe">1365-2036</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="547" to="552" />
			<date type="published" when="1997-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Impact of irritable bowel syndrome on patients?? lives: development and psychometric documentation of a disease-specific measure for use in clinical trials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">F</forename><surname>Longstreth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roger</forename><surname>Bolus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruce</forename><surname>Naliboff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lin</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K??roly</forename><forename type="middle">R</forename><surname>Kulich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonas</forename><surname>Carlsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emeran</forename><forename type="middle">A</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J??rgen</forename><surname>Naesdal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ingela</forename><forename type="middle">K</forename><surname>Wiklund</surname></persName>
		</author>
		<idno type="DOI">10.1097/00042737-200504000-00004</idno>
		<idno type="PMID">15756093</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Gastroenterology &amp; Hepatology</title>
		<title level="j" type="abbrev">European Journal of Gastroenterology &amp; Hepatology</title>
		<idno type="ISSN">0954-691X</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="411" to="420" />
			<date type="published" when="2005-04" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Stool Form Scale as a Useful Guide to Intestinal Transit Time</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">W</forename><surname>Heaton</surname></persName>
		</author>
		<idno type="DOI">10.3109/00365529709011203</idno>
		<idno type="PMID">9299672</idno>
	</analytic>
	<monogr>
		<title level="j">Scandinavian Journal of Gastroenterology</title>
		<title level="j" type="abbrev">Scandinavian Journal of Gastroenterology</title>
		<idno type="ISSN">0036-5521</idno>
		<idno type="ISSNe">1502-7708</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="920" to="924" />
			<date type="published" when="1997-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Pain Affect Encoded in Human Anterior Cingulate But Not Somatosensory Cortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Rainville</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">H</forename><surname>Duncan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Carrier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Bushnell</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.277.5328.968</idno>
		<idno type="PMID">9252330</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/db29/eed2bd2a310a8ea848a1056805e2bbb1e754.pdf" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="issue">5328</biblScope>
			<biblScope unit="page" from="968" to="971" />
			<date type="published" when="1997-08-15" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Physiological effects of emotion: assessment via hypnosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Houghton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">E</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Maxton</surname></persName>
		</author>
		<idno type="DOI">10.1016/0140-6736(92)90394-i</idno>
		<idno type="PMID">1352012</idno>
		<idno type="PII">0140-6736(92)90394-I</idno>
		<idno type="ark">ark:/67375/6H6-ZMRQT9FP-1</idno>
		<idno type="istexId">667F394AE988B5491582C5A12D8817C5A314923F</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="issue">8811</biblScope>
			<biblScope unit="page" from="69" to="72" />
			<date type="published" when="1992-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Houghton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Calvert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Larder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">M</forename><surname>Gonsalkorale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Whelan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Randles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Cruickshanks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2036.2003.01486.x</idno>
		<idno type="PMID">12641511</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/b76b/c1aebcf95e6615f7e1946c33fc5208088b6b.pdf" />
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology and Therapeutics</title>
		<title level="j" type="abbrev">Aliment Pharmacol Ther</title>
		<idno type="ISSN">0269-2813</idno>
		<idno type="ISSNe">1365-2036</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="635" to="642" />
			<date type="published" when="2003-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><forename type="middle">M</forename><surname>Gonsalkorale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brenda</forename><forename type="middle">B</forename><surname>Toner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Whorwell</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0022-3999(03)00076-x</idno>
		<idno type="PMID">15046962</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<title level="j" type="abbrev">Journal of Psychosomatic Research</title>
		<idno type="ISSN">0022-3999</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="271" to="278" />
			<date type="published" when="2004-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
